BMCS OTC
BioTech Medics, Inc.
1W: +0.0%
1M: +100.0%
3M: +100.0%
YTD: -97.5%
1Y: -97.7%
3Y: -98.7%
5Y: -99.6%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$27K
-60.4% ▼
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$27K
-60.4% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$102
-93.0% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$61K | -$110K | -$323K | -$115K | -$6K |
| Depreciation & Amort. | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $61K | $125K | $141K | $98K | -$21K |
| Other Non-Cash Items | $0 | -$45K | $0 | $0 | $0 |
| Operating Cash Flow | $0 | -$30K | -$182K | -$17K | -$27K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | -$373 | -$2K | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | -$70M | $0 | -$30M |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$373 | -$70M | $0 | -$30M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $27K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 | $18K | $0 |
| Financing Cash Flow | $0 | $30K | $70M | $18K | $30M |
| Net Change in Cash | $0 | $9 | -$735 | $1K | $102 |
| Cash End of Period | $0 | $9 | -$726 | $726 | $102 |
| Free Cash Flow | $0 | -$30K | -$184K | -$17K | -$27K |